These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33980035)

  • 1. Correction of Familial LCAT Deficiency by AAV-hLCAT Prevents Renal Injury and Atherosclerosis in Hamsters-Brief Report.
    Guo M; Ma S; Xu Y; Huang W; Gao M; Wu X; Dong X; Wang Y; Liu G; Xian X
    Arterioscler Thromb Vasc Biol; 2021 Jul; 41(7):2141-2148. PubMed ID: 33980035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous Atherosclerosis in Aged LCAT-Deficient Hamsters With Enhanced Oxidative Stress-Brief Report.
    Guo M; Liu Z; Xu Y; Ma P; Huang W; Gao M; Wang Y; Liu G; Xian X
    Arterioscler Thromb Vasc Biol; 2020 Dec; 40(12):2829-2836. PubMed ID: 32998519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia.
    Conca P; Pileggi S; Simonelli S; Boer E; Boscutti G; Magnolo L; Tarugi P; Penco S; Franceschini G; Calabresi L; Gomaraschi M
    J Clin Lipidol; 2012; 6(3):244-50. PubMed ID: 22658148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review on lecithin:cholesterol acyltransferase deficiency.
    Saeedi R; Li M; Frohlich J
    Clin Biochem; 2015 May; 48(7-8):472-5. PubMed ID: 25172171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis.
    Oldoni F; Baldassarre D; Castelnuovo S; Ossoli A; Amato M; van Capelleveen J; Hovingh GK; De Groot E; Bochem A; Simonelli S; Barbieri S; Veglia F; Franceschini G; Kuivenhoven JA; Holleboom AG; Calabresi L
    Circulation; 2018 Sep; 138(10):1000-1007. PubMed ID: 29748187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [LCAT deficiency: a nephrological diagnosis].
    Boscutti G; Calabresi L; Pizzolitto S; Boer E; Bosco M; Mattei PL; Martone M; Milutinovic N; Berbecar D; Beltram E; Franceschini G
    G Ital Nefrol; 2011; 28(4):369-82. PubMed ID: 21809306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor?
    Rousset X; Shamburek R; Vaisman B; Amar M; Remaley AT
    Curr Atheroscler Rep; 2011 Jun; 13(3):249-56. PubMed ID: 21331766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very low levels of HDL cholesterol and atherosclerosis, a variable relationship--a review of LCAT deficiency.
    Savel J; Lafitte M; Pucheu Y; Pradeau V; Tabarin A; Couffinhal T
    Vasc Health Risk Manag; 2012; 8():357-61. PubMed ID: 22701329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disturbed apolipoprotein A-I-containing lipoproteins in fish-eye disease are improved by the lecithin:cholesterol acyltransferase produced by gene-transduced adipocytes in vitro.
    Asada S; Kuroda M; Aoyagi Y; Bujo H; Tanaka S; Konno S; Tanio M; Ishii I; Aso M; Saito Y
    Mol Genet Metab; 2011 Feb; 102(2):229-31. PubMed ID: 21074466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of hypoalphalipoproteinemia in LDL receptor-deficient rabbits by lecithin:cholesterol acyltransferase.
    Brousseau ME; Wang J; Demosky SJ; Vaisman BL; Talley GD; Santamarina-Fojo S; Brewer HB; Hoeg JM
    J Lipid Res; 1998 Aug; 39(8):1558-67. PubMed ID: 9717715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AAV8-mediated long-term expression of human LCAT significantly improves lipid profiles in hCETP;Ldlr(+/-) mice.
    Chen Z; Chu D; Castro-Perez JM; Ni W; Zhang A; Krsmanovic ML; Xie D; Shah V; Stout SJ; McLaren DG; Stefanni AC; Lee SH; Roddy TP; Plump AS; Hubbard BK; Vogt TF; Zhou HH
    J Cardiovasc Transl Res; 2011 Dec; 4(6):801-10. PubMed ID: 21822774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel LCAT mutation (Phe382-->Val) in a kindred with familial LCAT deficiency and defective apolipoprotein B-100.
    Nanjee MN; Stocks J; Cooke CJ; Molhuizen HO; Marcovina S; Crook D; Kastelein JP; Miller NE
    Atherosclerosis; 2003 Sep; 170(1):105-13. PubMed ID: 12957688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CER-001 ameliorates lipid profile and kidney disease in a mouse model of familial LCAT deficiency.
    Ossoli A; Strazzella A; Rottoli D; Zanchi C; Locatelli M; Zoja C; Simonelli S; Veglia F; Barbaras R; Tupin C; Dasseux JL; Calabresi L
    Metabolism; 2021 Mar; 116():154464. PubMed ID: 33309714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a new LCAT mutation causing familial LCAT deficiency (FLD) and the role of APOE as a modifier gene of the FLD phenotype.
    Baass A; Wassef H; Tremblay M; Bernier L; Dufour R; Davignon J
    Atherosclerosis; 2009 Dec; 207(2):452-7. PubMed ID: 19515369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of lecithin:cholesterol acyltransferase in the modulation of cardiometabolic risks - a clinical update and emerging insights from animal models.
    Ng DS
    Biochim Biophys Acta; 2012 Apr; 1821(4):654-9. PubMed ID: 22326749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?
    Kunnen S; Van Eck M
    J Lipid Res; 2012 Sep; 53(9):1783-99. PubMed ID: 22566575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel LCAT (Lecithin:Cholesterol Acyltransferase) Activator DS-8190a Prevents the Progression of Plaque Accumulation in Atherosclerosis Models.
    Sasaki M; Delawary M; Sakurai H; Kobayashi H; Nakao N; Tsuru H; Fukushima Y; Honzumi S; Moriyama S; Wada N; Kaneko T; Yamada K; Terasaka N; Kubota K
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):360-376. PubMed ID: 33086872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of LCAT activity in the golden Syrian hamster elicits pro-atherogenic dyslipidemia and enhanced atherosclerosis.
    Dong Z; Shi H; Zhao M; Zhang X; Huang W; Wang Y; Zheng L; Xian X; Liu G
    Metabolism; 2018 Jun; 83():245-255. PubMed ID: 29526535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits.
    Brousseau ME; Kauffman RD; Herderick EE; Demosky SJ; Evans W; Marcovina S; Santamarina-Fojo S; Brewer HB; Hoeg JM
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):450-8. PubMed ID: 10669643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular disease.
    Calabresi L; Simonelli S; Gomaraschi M; Franceschini G
    Atherosclerosis; 2012 Jun; 222(2):299-306. PubMed ID: 22189200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.